跳至主要内容
临床试验/CTRI/2013/05/003705
CTRI/2013/05/003705已完成2 期

A comparative clinico-experimental evaluation of Rasayana Drugs administered orally & by Basti in the management of Madhumeha w. s. r. to Type-II Diabetes Mellitus

Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Patient of NIDDM with blood sugar level,
  • FBS- 126 to 220 mg/dl or
  • PPBS- 180 to 300 mg/dl.

排除标准

  • Patients having age less than 20 years & above 60 years.
  • Patients of Type-I Diabetes or the patients of Type-II Diabetes taking Insulin.
  • Patients having complications of Diabetes like Nephropathy, Retinopathy, Diabetic Foot, Carbuncles etc.
  • Patients having Diabetes in association with other endocrinopathies like Phaeochromocytoma, Acromegaly, Cushingâ??s syndrome, hyperthyroidism etc.
  • Patients having drug or chemical induced Type II Diabetes, like glucocorticoids induced or thyroid hormone induced etc.
  • Patients with genetic syndromes associated with Type II Diabetes like Downâ??s Syndrome, Klinefelterâ??s Syndrome, Turnerâ??s Syndrome etc.
  • Patients complicated with any Cardiovascular diseases, Renal diseases, Carcinoma or any other disease effecting multiple body systems and pregnant women etc.
  • Patients contraindicated for Bastikarma as per classics

研究者

发起方
Institute for post graduate teaching and research in Ayurveda Gujarat Ayurved University Jamnagar

相似试验